Monitoring Progression of Ductal Carcinoma In Situ Using Photoacoustics and Contrast-Enhanced Ultrasound

被引:8
作者
Margolis, Ryan [1 ,2 ]
Wessner, Corinne [1 ,2 ]
Stanczak, Maria [1 ,2 ]
Liu, Ji-Bin [1 ,2 ]
Li, Jingzhi [1 ,2 ]
Nam, Kibo [1 ,2 ]
Forsberg, Flemming [1 ,2 ]
Eisenbrey, John R. [1 ,2 ]
机构
[1] Thomas Jefferson Univ, Dept Radiol, Philadelphia, PA 19107 USA
[2] UT Southwestern, 5323 Harry Hines Blvd, Dallas, TX 75235 USA
关键词
BREAST-CANCER; HYPOXIA; MRI; MAMMOGRAPHY; TOMOGRAPHY; PREVENTION; EXERCISE; SOCIETY;
D O I
10.1016/j.tranon.2019.04.018
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast cancer is the leading form of cancer in women, accounting for approximately 41,400 deaths in 2018. While a variety of risk factors have been identified, physical exercise has been linked to reducing both the risk and aggressiveness of breast cancer. Within breast cancer, ductal carcinoma in situ (DCIS) is a common finding. However, less than 25% of DCIS tumors actually progress into invasive breast cancer, resulting in overtreatment. This overtreatment is due to a lack of predictive precursors to assess aggressiveness and development of DCIS. We hypothesize that tissue oxygenation and perfusion measured by photoacoustic and contrast-enhanced ultrasound imaging, respectively, can predict DCIS aggressiveness. To test this, 20 FVB/NJ and 20 SV40Tag mice that genetically develop DCIS-like breast cancers were divided evenly into exercise and control groups and imaged over the course of 6 weeks. Tissue oxygenation was a predictive precursor to invasive breast cancer for FVB/NJ mice (P = 0.015) in the early stages of tumor development. Meanwhile, perfusion results were inconclusive (P > 0.2) as a marker for disease progression. Moreover, voluntary physical exercise resulted in lower weekly tumor growth and significantly improved median survival (P = 0.014).
引用
收藏
页码:973 / 980
页数:8
相关论文
共 35 条
[1]   Mesothelin, a novel immunotherapy target for triple negative breast cancer [J].
Tchou, Julia ;
Wang, Liang-Chuan ;
Selven, Ben ;
Zhang, Hongtao ;
Conejo-Garcia, Jose ;
Borghaei, Hossein ;
Kalos, Michael ;
Vondeheide, Robert H. ;
Albelda, Steven M. ;
June, Carl H. ;
Zhang, Paul J. .
BREAST CANCER RESEARCH AND TREATMENT, 2012, 133 (02) :799-804
[2]  
[Anonymous], 2017, Colorectal cancer facts and figures 2017-2019, DOI [10.1101/gad.1593107, DOI 10.1101/GAD.1593107]
[3]   Biomedical photoacoustic imaging [J].
Beard, Paul .
INTERFACE FOCUS, 2011, 1 (04) :602-631
[4]  
Blumen H, 2016, AM HEALTH DRUG BENEF, V9, P23
[5]   Hypoxia promotes tumor growth in linking angiogenesis to immune escape [J].
Chouaib, Salem ;
Messai, Yosra ;
Couve, Sophie ;
Escudier, Bernard ;
Hasmim, Meriem ;
Noman, Muhammad Zaeem .
FRONTIERS IN IMMUNOLOGY, 2012, 3
[6]  
Dastgheyb SS, 2014, PDL HANDB SER, P253, DOI 10.1016/B978-0-323-22805-3.00011-6
[7]   Multispectral Optoacoustic Tomography (MSOT) of Human Breast Cancer [J].
Diot, Gael ;
Metz, Stephan ;
Noske, Aurelia ;
Liapis, Evangelos ;
Schroeder, Barbara ;
Ovsepian, Saak V. ;
Meier, Reinhard ;
Rummeny, Ernst ;
Ntziachristos, Vasilis .
CLINICAL CANCER RESEARCH, 2017, 23 (22) :6912-6922
[8]   Reproducibility of Contrast-Enhanced Ultrasound in Mice with Controlled Injection [J].
Dizeux, Alexandre ;
Payen, Thomas ;
Barrois, Guillaume ;
Buffello, Delphine Le Guillou ;
Bridal, S. Lori .
MOLECULAR IMAGING AND BIOLOGY, 2016, 18 (05) :651-658
[9]   Contrast-enhanced ultrasound for molecular imaging of angiogenesis [J].
Eisenbrey, J. R. ;
Forsberg, F. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 :S138-S146
[10]   Development and optimization of a doxorubicin loaded poly(lactic acid) contrast agent for ultrasound directed drug delivery [J].
Eisenbrey, J. R. ;
Burstein, O. Mualem ;
Kambhampati, R. ;
Forsberg, F. ;
Liu, J. -B. ;
Wheatley, M. A. .
JOURNAL OF CONTROLLED RELEASE, 2010, 143 (01) :38-44